Mandate

Vinge Advises VocaLink

May 16, 2008

BGC – Bankgirocentralen has entered into an agreement with Brittish VocaLink concerning a takeover of operations and development of the bank giro services. Vinge acted as advisors to Vocalink. Vocalink – specialised provider of transaction services for banks – will gradually take over, through a specialized out sourcing agreement, operations and development of the BGC’s services. The agreement was entered into yesterday. Efforts to shift the service will commence during May 2008 and shall be implemented by the start of 2010. Payment transactions will thereafter occur through VocaLink. However BGC’s role and responsibility towards Swedish banks, companies and authorities will remain the same. BGC, wholly owned by Swedish commercial banks, play a central role in the mediation of payments and data between banks and their customers. On a daily basis BGC mediates transactions for SEK 25 to 50 billion.   

Vinge’s team included partner Björn Gustavsson, joined by Lisa Barnekow, Fredrik Dahl, Per Westman and Maria Schultzberg.     

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025